• Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

    1 month ago - By Xconomy

    A contraceptive patch developed by Agile Therapeutics was awarded FDA approval late Friday, clearing the way for a new birth control option to reach the market. The Agile product, called Twirla, deliver delivers a combination of hormones via a proprietary skin patch applied once a week. It's the first FDA approved product for the Princeton, NJ-based company. For Agile, the regulatory approval has been a long time coming. The company submitted applications for FDA review twice before, receiving rejections in 2013 and 2017. The 2017 rejection cited deficiencies in the manufacturing process...
    Read more ...